1 The modification of the vasodilator effect of calcitonin gene-related peptide (CGRP) by a panel of monoclonal antibodies (MAbs), which map to discrete epitopes on the CGRP molecule, was investigated in pig coronary artery rings (PCA). The preparations were pre-constricted with acetylcholine (3 x 10-7M) and concentration-response curves to CGRP (2 x 10-'0-2.56 x 10-8M) were obtained in the presence or absence of each MAb. 2 CGRP caused a concentration-dependent relaxation of PCAs which reached a maximum (98.2 ± 4.8%, n = 25) at 1.28 x 10-8M and gave an EC50 of 3.8 ± 0.8 x 10-9M. 3 Two MAbs which map to the N-terminal, CNl and CRA3, did not affect the CGRP response whilst a third, CRA5, significantly inhibited its effect. 4 The C-terminal MAb, CRA2, did not modify the CGRP response whilst, in contrast, CB3 (Cterminal) potentiated its effect. A similar augmentation of the CGRP-induced vasodilatation was seen in the presence of the middle-region MAb, CRA8. 5 These results suggest that regional specific MAbs can modify the vasodilator effect of CGRP causing either inhibition (CRA5, N-terminal) or potentiation (CB3, C-terminal; CRA8, middle region).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.